Conversely, reduced Gal-3 expression in tumor tissue compared with normal tissue was reported in ovarian cancer [10], uterine adenocarcinoma [11], breast cancer [12], [13] and cervical neoplasia [14]. This evidence concerns the gene LGALS3 and breast carcinoma.